Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
April 21, 2006
Therapeutic and palliative options for diffuse neuroendocrine metastatic disease
Kyle Holen
Clinical Colorectal Cancer
|
June 8, 2007
Treatment with panitumumab after a severe infusion reaction to cetuximab in a patient with metastatic colorectal cancer: a case report
James Heun, Kyle Holen
Molecular Cancer Therapeutics
|
June 16, 2005
ZM336372, a Raf-1 activator, suppresses growth and neuroendocrine hormone levels in carcinoid tumor cells
Jamie J Van Gompel, Muthusamy Kunnimalaiyaan, Kyle Holen, et al.
The Oncologist
|
December 19, 2008
Carcinoid tumors
Scott N Pinchot, Kyle Holen, Rebecca S Sippel, et al.
The Journal of Surgical Research
|
December 25, 2009
ZM336372 induces apoptosis associated with phosphorylation of GSK-3beta in pancreatic adenocarcinoma cell lines
Dustin Deming, Peter Geiger, Herbert Chen, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
February 27, 2008
ZM336372, a Raf-1 activator, causes suppression of proliferation in a human hepatocellular carcinoma cell line
Dustin Deming, Peter Geiger, Herbert Chen, et al.
Investigational New Drugs
|
October 10, 2007
The pharmacokinetics, toxicities, and biologic effects of FK866, a nicotinamide adenine dinucleotide biosynthesis inhibitor
Kyle Holen, Leonard B Saltz, Ellen Hollywood, et al.
Anticancer Research
|
April 3, 2014
Effect of co-administration of ketoconazole, a strong CYP3A inhibitor, on the pharmacokinetics, safety and tolerability of navitoclax, a first-in-class oral Bcl-2 family inhibitor, in cancer patients
Ahmed Hamed Salem, Jianning Yang, Alison Graham, et al.
Cancer Chemotherapy and Pharmacology
|
May 5, 2010
Population pharmacokinetics of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (Triapine®) in cancer patients
Jill Kolesar, Richard C Brundage, Marcia Pomplun, et al.
Archives of Surgery (Chicago, Ill. : 1960)
|
October 18, 2006
Metastatic neuroendocrine hepatic tumors: resection improves survival
Sandeepa Musunuru, Herbert Chen, Sharad Rajpal, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
April 21, 2006
Therapeutic and palliative options for diffuse neuroendocrine metastatic disease
Kyle Holen
Clinical Colorectal Cancer
|
June 8, 2007
Treatment with panitumumab after a severe infusion reaction to cetuximab in a patient with metastatic colorectal cancer: a case report
James Heun, Kyle Holen
Molecular Cancer Therapeutics
|
June 16, 2005
ZM336372, a Raf-1 activator, suppresses growth and neuroendocrine hormone levels in carcinoid tumor cells
Jamie J Van Gompel, Muthusamy Kunnimalaiyaan, Kyle Holen, et al.
The Oncologist
|
December 19, 2008
Carcinoid tumors
Scott N Pinchot, Kyle Holen, Rebecca S Sippel, et al.
The Journal of Surgical Research
|
December 25, 2009
ZM336372 induces apoptosis associated with phosphorylation of GSK-3beta in pancreatic adenocarcinoma cell lines
Dustin Deming, Peter Geiger, Herbert Chen, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
February 27, 2008
ZM336372, a Raf-1 activator, causes suppression of proliferation in a human hepatocellular carcinoma cell line
Dustin Deming, Peter Geiger, Herbert Chen, et al.
Investigational New Drugs
|
October 10, 2007
The pharmacokinetics, toxicities, and biologic effects of FK866, a nicotinamide adenine dinucleotide biosynthesis inhibitor
Kyle Holen, Leonard B Saltz, Ellen Hollywood, et al.
Anticancer Research
|
April 3, 2014
Effect of co-administration of ketoconazole, a strong CYP3A inhibitor, on the pharmacokinetics, safety and tolerability of navitoclax, a first-in-class oral Bcl-2 family inhibitor, in cancer patients
Ahmed Hamed Salem, Jianning Yang, Alison Graham, et al.
Cancer Chemotherapy and Pharmacology
|
May 5, 2010
Population pharmacokinetics of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (Triapine®) in cancer patients
Jill Kolesar, Richard C Brundage, Marcia Pomplun, et al.
Archives of Surgery (Chicago, Ill. : 1960)
|
October 18, 2006
Metastatic neuroendocrine hepatic tumors: resection improves survival
Sandeepa Musunuru, Herbert Chen, Sharad Rajpal, et al.
Page
of 2